Nivolumab plus ipilimumab vs nivolumab for previously treated patients with stage IV squamous cell lung cancer: the lung-MAP S1400I phase 3 randomized clinical trial - Gettinger, S N; Redman, M W; Bazhenova, L (JAMA Oncol, 2021)
et al.